updates from the phase i/ii bruin study: pirtobrutinib in cll
Published 2 years ago • 123 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
2:40
epic update: observational study of first-line acalabrutinib treatment for cll
-
3:15
overview of a phase ib study of venetoclax and obinutuzumab in cll
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:56
the future of fixed-duration therapy in cll
-
11:59
an introduction to on-section clem
-
4:19
cll: what is 'watch & wait' and what can a patient do during this phase?
-
1:02:10
what is cll? - diagnosis and treatment
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
9:00
overview of cll therapies and sequencing of therapies
-
3:29
how the management of cll is evolving
-
5:52
understanding ultra high-risk cll and advances with ibrutinib therapy
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
3:10
ascend: acalabrutinib in r/r cll
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
1:27
what is cll treatment research focused on?
-
1:28
overview of resonate-2 clinical trial of ibrutinib in cll
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:25
an insight into the future treatment landscape of cll
-
2:52
updated analysis of phase iii trial of idelalisib combined with bendamustine and rituximab in cll